Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

103.58 +0.49 (+0.48%)

Streaming Delayed Price Updated: 1:50 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

60 61 Next >

CureVac, GS Partner Release Data On Influenza Vaccine Study ↗

April 04, 2024

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A...

Via Benzinga

The 3 Best Bargain Stocks to Buy in Q2 2024 ↗

March 31, 2024

For those who don’t want to chase what everyone else is acquiring, these are intriguing ideas for best bargain stocks to buy.

Via InvestorPlace

3 Biotech Stocks to Buy for the Next Bull Run: March 2024 ↗

March 26, 2024

These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.

Via InvestorPlace

Cracking The Code: Understanding Analyst Reviews For BioNTech ↗

March 21, 2024

Via Benzinga

BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript ↗

March 20, 2024

BNTX earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 20, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...

Via Benzinga

BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials ↗

March 20, 2024

BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandemic with their jointly developed vaccine.

Via Benzinga

Stocks Quietly Higher As Central Bank Wraps Up Meeting ↗

March 20, 2024

Stocks are cautiously higher ahead of the conclusion of the central bank's policy meeting.

Via Talk Markets

Topics Economy

BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q4 2023 ↗

March 20, 2024

BNTX stock results show that BioNTech missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts ↗

March 20, 2024

BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance.

Via Investor's Business Daily

Why Is BioNTech Stock Trading Lower On Wednesday? ↗

March 20, 2024

BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5-€3.1 billion,...

Via Benzinga

Earnings Outlook For BioNTech ↗

March 19, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For BioNTech ↗

February 20, 2024

Via Benzinga

US Stock Futures Stall As Traders Await Fed Chair Powell's Decision; Analyst Sees S&P 500 Showing 'Signs Of Near-Term Top' ↗

March 20, 2024

Investors remain cautious ahead of the Federal Reserve‘s interest rate decision, with stock futures on Wednesday hinting at a lower opening.

Via Benzinga

Topics Economy Stocks

Earnings Scheduled For March 20, 2024 ↗

March 20, 2024

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.

Via Benzinga

Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio ↗

March 13, 2024

One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.

Via InvestorPlace

The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar ↗

March 06, 2024

Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation.

Via InvestorPlace

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success ↗

March 06, 2024

With excellent financial health and great prospects, these three biotech stocks just may be the the next stars of the sector.

Via InvestorPlace

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound ↗

March 04, 2024

While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities.

Via InvestorPlace

It’s Time! 3 Dodgy Pharma Stocks to Sell in February ↗

March 04, 2024

Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

March 04, 2024

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

February 12, 2024

Via Benzinga

3 Blue-Chip Stocks to Buy at a 52-Week Low in February ↗

February 07, 2024

Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price.

Via InvestorPlace

Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets ↗

February 03, 2024

Inmagene Biopharma of Shanghai transferred 7.5% of its shares to HutchMed for global rights to two clinical stage immunology assets. It will also be responsible for up to $230 million in milestones.

Via Talk Markets

3 Pharma Stocks to Sell in February Before They Crash and Burn ↗

February 02, 2024

The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.

Via InvestorPlace

Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations ↗

February 02, 2024

The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.

Via Benzinga

Topics Economy

Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60% ↗

January 30, 2024

Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.

Via Benzinga

Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China ↗

January 27, 2024

ArriVent BioPharma priced its upsized Nasdaq IPO at $18 dollars per share, raising $175 million. The company’s stated goal is to find promising novel assets from China and other countries, which it...

Via Talk Markets

Topics Initial Public Offering

Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January ↗

January 25, 2024

These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.

Via InvestorPlace

Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

January 23, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.